Crewe Advisors LLC Sells 504 Shares of Solventum Co. (NYSE:SOLV)

Crewe Advisors LLC cut its stake in Solventum Co. (NYSE:SOLV) by 56.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 382 shares of the company’s stock after selling 504 shares during the quarter. Crewe Advisors LLC’s holdings in Solventum were worth $27,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. LRI Investments LLC acquired a new stake in Solventum during the first quarter worth approximately $43,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Solventum in the 1st quarter valued at about $5,889,000. EverSource Wealth Advisors LLC bought a new stake in Solventum in the first quarter valued at approximately $30,000. GAMMA Investing LLC acquired a new stake in Solventum during the 2nd quarter valued at approximately $74,000. Finally, Massmutual Trust Co. FSB ADV bought a new position in Solventum during the 2nd quarter worth approximately $34,000.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on SOLV shares. Stifel Nicolaus started coverage on shares of Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective for the company. Morgan Stanley lifted their price objective on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. The Goldman Sachs Group raised their target price on Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research note on Monday, August 12th. Wolfe Research began coverage on Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating on the stock. Finally, Piper Sandler lifted their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $68.00.

Solventum Stock Up 1.7 %

Shares of SOLV opened at $70.81 on Monday. The business’s fifty day moving average is $70.53 and its 200 day moving average is $62.30. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.